ε-Aminocaproic Acid and Clinical Value in Cardiac Anesthesia

Objective The primary aim was to compare the “clinical value” of tranexamic acid (TXA) with ε-aminocaproic acid (EACA) when used for blood conservation during high-risk cardiac surgery. Design Data previously reported by the Blood Conservation Using Antifibrinolytics in a Randomized Trial (BART) stu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiothoracic and vascular anesthesia 2011-02, Vol.25 (1), p.16-19
Hauptverfasser:	Raghunathan, Karthik, MD, MPH, Connelly, Neil Roy, MD, Kanter, Gary J., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Aminocaproic Acid - adverse effects Aminocaproic Acid - economics Aminocaproic Acid - therapeutic use Anesthesia Anesthesia & Perioperative Care Antifibrinolytic Agents - adverse effects Antifibrinolytic Agents - economics Antifibrinolytic Agents - therapeutic use antifibrinolytics Aprotinin - adverse effects Aprotinin - therapeutic use blood conservation Blood Loss, Surgical - prevention & control cardiac anesthesia cardiac surgery Cardiac Surgical Procedures - economics Cardiac Surgical Procedures - methods clinical value Critical Care Data Interpretation, Statistical Dose-Response Relationship, Drug Humans Multicenter Studies as Topic Postoperative Hemorrhage - chemically induced Postoperative Hemorrhage - etiology Randomized Controlled Trials as Topic tranexamic acid Tranexamic Acid - adverse effects Tranexamic Acid - therapeutic use Treatment Outcome ε-aminocaproic acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!